The Philippines’ pharmaceutical market is projected to grow from P525 billion in 2025 to P759 billion by 2030, with a compound annual growth rate of 7.6 percent, according to BMI Research.
The growth is expected to be driven by investments in local drug manufacturing and government initiatives, including a “green lane” to streamline regulatory processes for new facilities.
Despite these efforts, the country faces a $2.3-billion pharmaceutical trade deficit and remains heavily dependent on imported medicines.
Challenges to the sector’s expansion include limited financial resources, skilled human capital, and lengthy FDA approval processes that can delay product launches for years.
BMI noted that while policy measures support growth, structural constraints may continue to limit advanced pharmaceutical manufacturing and research in the Philippines.
Source: PhilNews24 | March 23, 2026
PHILIPPINE PHARMA MARKET GROWTH COULD TOP P759 BILLION BY 2030
Latest from Business
Dermorepubliq, a TikTok Philippines science-based skincare brand, won Gold at the 2026 Asia-Pacific Stevie Awards for
Former finance secretary Gary Teves has called for a comprehensive review of the government’s Lifeline Rate
Inflation in the Philippines accelerated to 7.2 percent in April, driven by rising fuel and food
The Philippine aviation industry recorded the fastest growth in Southeast Asia in April despite rising oil
Inflation in the Philippines accelerated to 7.2% in April, its highest level in three years, driven